Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-28 · accession 0001415889-23-010459 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-30 | 2023-06-28+ | FENC | Andrade Robert | CFO | S - Sale+OE | $8.93 | -25.0K | 124.7K | -17% | -$223.3K |
| D | 2023-06-30 | 2023-06-30 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | +25.0K | 149.7K | +20% | +$61.3K |
| D | 2023-06-30 | 2023-06-30 | FENC | Andrade Robert | CFO | M - OptEx | $2.45 | -25.0K | 605.0K | -4% | -$61.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2023-06-28 | S | D | 10,000 | $8.99 | 139,721 | D | — | — | (F1) Represents shares sold pursuant to a 10b5-1 plan on June 28, 2023. |
| 2 | Common | Common shares | 2023-06-29 | S | D | 7,500 | $8.97 | 132,221 | D | — | — | (F2) Represents shares sold pursuant to a 10b5-1 plan on June 29, 2023. |
| 3 | Common | Common shares | 2023-06-30 | S | D | 7,500 | $8.82 | 124,721 | D | — | — | (F3) Represents shares sold pursuant to a 10b5-1 plan on June 30, 2023. |
| 4 | Common | Common shares | 2023-06-30 | M | A | 25,000 | $2.45 | 149,721 | D | — | — | (F4) Shares aquired through the exercise of option contract with a strike price of $2.45 and an expiration date of July 5, 2026. |
| 5 | Derivative | Common Shares | 2023-06-30 | M | D | 25,000 | $2.45 | 605,000 | D | $2.45 · 2016-07-05 to 2026-07-05 | 25,000 Options | (F5) Represents options granted on July 5, 2016, with a strike price of $2.45 and expiration date of July 5, 2026. |